Please assess the completion status of the following clinical trial:

Trial Title: A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The patient meets Autistic disorder diagnostic criteria defined in DSM-IV-TR.~* The patient has completed the 031-11-002 study (the patient has visited the hospital during week8)~* Inpatient or outpatient status~Exclusion Criteria:~* The patient is currently diagnosed with another disorder on the autism spectrum in DSM-IV-TR, including Asperger's, Rett's Disorder, PDD-NOS, Childhood Disintegrative Disorder, or Fragile-X Syndrome.~* Patients who fall under a contraindication listed in the ABILIFY package insert~* Others

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Aripiprazole (Type: EXPERIMENTAL): administered orally once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).